SÜREYYA BOZKURT

Targeting Integrin α2 to Overcome Imatinib Resistance in Chronic Myeloid Leukemia Cells

Hekmatshoar Y.

Biomolecules, 2025

Identification of common genes and pathways underlying imatinib and nilotinib treatment in CML: a Bioinformatics Study

Hekmatshoar Y.

Nucleosides Nucleotides and Nucleic Acids, 2024

Phenotypic and functional characterization of subpopulation of Imatinib resistant chronic myeloid leukemia cell line

Hekmatshoar Y.

Advances in Medical Sciences, 2023

Downregulation of Stearoyl-CoA Desaturase 1 (SCD-1) Promotes Resistance to Imatinib in Chronic Myeloid Leukemia

Gunes B.A.

Mediterranean Journal of Hematology and Infectious Diseases, 2023

Novel RUNX1 Variation in B-cell Acute Lymphoblastic Leukemia

Qipa E.

Mediterranean Journal of Hematology and Infectious Diseases, 2023

First report of t(1;9)(q21;q34) in Fanconi anemia as a preceeding chromosomal aberration before leukemia development

Bozkurt S.

Kuwait Medical Journal, 2022

First report of t(1;15)(q21;q11.2) and t(1;21)(q21;q11.2) anomalies in Burkitt Lymphoma

Bozkurt S.

Kuwait Medical Journal, 2021

New mutations in KCNT2 gene causing early infantile epileptic encephalopathy type 57: Case study and literature review

Alagoz M.

Acta Biochimica Polonica, 2020

Rare cytogenetic anomalies in two pediatric patients with acute leukemia

Bozkurt S.

Turkish Journal of Hematology, 2020

Determining the frequency of iron overload at diagnosis in de novo acute myeloid leukemia patients with multilineage dysplasia or myelodysplasia-related changes: a case control study

Yavuz B.

Journal of Hematopathology, 2019

Aggressive Clinicopathological Course of Myeloma with t(3;16) (q21;q22) Cytogenetic Abnormality

Bozkurt S.

Turkish Journal of Haematology Official Journal of Turkish Society of Haematology, 2019

Hematological neoplastic disorders with chromosome 3 abnormalities

Bozkurt S.

Acta Medica Mediterranea, 2019